# COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2

> **NCT04354766** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 10 (actual)

## Conditions studied

- COVID

## Interventions

- **OTHER:** Blood sample

## Key facts

- **NCT ID:** NCT04354766
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-29
- **Primary completion:** 2020-05-18
- **Final completion:** 2020-05-18
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04354766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04354766, "COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04354766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*